NCT00349115View on ClinicalTrials.gov

TCD Followed by autoSCT for Newly Diagnosed MM Patients

PHASE2UnknownINTERVENTIONAL

Enrollment

43

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

June 30, 2008

Conditions

Multiple Myeloma

Interventions

DRUG

Thalidomide

Trial Locations (1)

519-809

RECRUITING

Je-Jung Lee, Hwsun-eup, Hwasun-gun

Sponsors

Collaborators (1)

Celgene Corporation

All Listed Sponsors

collaborator

Celgene Corporation

INDUSTRY

lead

Korean Multiple Myeloma Working Party

OTHER